Opportunity

SAM #75D30126R73375

CDC Awards GlaxoSmithKline Contract for Vaccines for Children (VFC) FY26 Program

Buyer

CDC Office of Acquisition Services

Posted

March 27, 2026

Identifier

75D30126R73375

NAICS

325412, 325414, 424210

This award notice announces a major contract from the Centers for Disease Control and Prevention (CDC) for the Vaccines for Children (VFC) FY26 program: - Government Buyer: - Department of Health and Human Services (HHS) - Centers for Disease Control and Prevention (CDC), Office of Acquisition Services - Awardee and OEM: - GlaxoSmithKline, LLC (GSK), a leading pharmaceutical manufacturer - Products/Services Requested: - Supply of vaccines for the VFC program - No specific vaccine products, part numbers, or quantities detailed in the notice - Notable Details: - Contract value is $1,465,091,900.00 - Procurement classified under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and product code 6505 (Drugs and Biologicals) - Place of performance is Georgia - No unique technical or delivery requirements specified beyond vaccine supply for the VFC program

View original listing